Transient inhibition of ROR-γT therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells - Withers, D R; Hepworth, M R; Wang, X; Mackley, E C; Halford, E E; Dutton, E E; Marriott, C L; Brucklacher-Waldert, V; Veldhoen, M; Kelsen, J; Baldassano, R N; Sonnenberg, G F (Nat Med, 2016)